JanOne is a biotechnology company dedicated to developing non-addictive treatments for diseases that cause severe pain, with a focus on reducing the need for opioid prescriptions. Their current focus is on treating peripheral artery disease (PAD), a condition affecting millions of Americans at risk for addiction when opioids are prescribed for pain relief. Through their research and development efforts, JanOne aims to address the root causes of pain and provide innovative solutions that offer pain relief without the risk of addiction. By advancing treatments like Jan101 for PAD, the company is working towards a future where pain management is safer and more effective for patients. Generated from the website

O'Neal Steel

A & I Bolt and Nut